Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Marimed (MRMD) over the last 8 years, with Q3 2025 value amounting to $392.6 million.

  • Marimed's Shares Outstanding (Diluted Average) rose 315.66% to $392.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.6 million, marking a year-over-year increase of 315.66%. This contributed to the annual value of $379.2 million for FY2024, which is 433.4% up from last year.
  • Latest data reveals that Marimed reported Shares Outstanding (Diluted Average) of $392.6 million as of Q3 2025, which was up 315.66% from $389.9 million recorded in Q2 2025.
  • Over the past 5 years, Marimed's Shares Outstanding (Diluted Average) peaked at $392.6 million during Q3 2025, and registered a low of $340.8 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $378.9 million (2021), whereas its average is $373.8 million.
  • Per our database at Business Quant, Marimed's Shares Outstanding (Diluted Average) soared by 4930.3% in 2021 and then plummeted by 952.68% in 2023.
  • Quarter analysis of 5 years shows Marimed's Shares Outstanding (Diluted Average) stood at $372.4 million in 2021, then rose by 2.12% to $380.3 million in 2022, then decreased by 4.44% to $363.4 million in 2023, then rose by 4.33% to $379.2 million in 2024, then rose by 3.55% to $392.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $392.6 million in Q3 2025, compared to $389.9 million in Q2 2025 and $382.6 million in Q1 2025.